6D72.13

ICD-11 MMS 2026-01

Amnestic disorder due to use of volatile inhalants

Description

All definitional requirements for amnestic disorder are met. The memory symptoms are judged to be the direct consequence of use of volatile inhalants. The intensity and duration of use of volatile inhalants must be known to be capable of producing memory impairment. The memory impairment may develop during or soon after volatile inhalant intoxication or withdrawal, but its intensity and duration are substantially in excess of those normally associated with these conditions. The symptoms are not better accounted for by another disorder or medical condition, as might be the case if the amnestic symptoms preceded the onset of use of volatile inhalants.

Index terms

  • Amnestic disorder due to use of volatile inhalants

Exclusions from above levels

  • 6D70 – Delirium
  • 6D71 – Mild neurocognitive disorder
  • http://id.who.int/icd/entity/546689346 – Dementia
Show allHide
  • http://id.who.int/icd/entity/1516623224 – Neurodevelopmental disorders
  • QE62 – Uncomplicated bereavement
  • QE84 – Acute stress reaction

Sibling codes

  • 6D72.10 – Amnestic disorder due to use of alcohol
  • 6D72.11 – Amnestic disorder due to use of sedatives, hypnotics or anxiolytics
  • 6D72.12 – Amnestic disorder due to other specified psychoactive substance including medications

Foundation entity

Amnestic disorder due to use of volatile inhalants – http://id.who.int/icd/entity/2081070847

Part of: 6D72.1: Amnestic disorder due to psychoactive substances including medications › 6D72: Amnestic disorder › 06: Mental, behavioural or neurodevelopmental disorders